Connect Biopharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CNTB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 May 26	BuyUS$371,610	Panacea Venture Management Co., Ltd.	Company	150,000	US$2.48
31 Mar 26	BuyUS$4,002,000	Panacea Venture Management Co., Ltd.	Company	1,160,000	US$3.45
24 Nov 25	SellUS$6,000,000	Panacea Venture Management Co., Ltd.	Company	2,000,000	US$3.00
30 Sep 25	BuyUS$73,200	Panacea Venture Management Co., Ltd.	Company	50,000	US$1.46

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CNTB?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	5,306,149	8.43%
Hedge Funds	5,388,486	8.56%
General Public	7,204,926	11.4%
Individual Insiders	10,506,144	16.7%
Institutions	11,645,065	18.5%
VC/PE Firms	22,913,083	36.4%

Dilution of Shares: CNTB only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 86.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
21.1%	Panacea Venture Management Co., Ltd.	13,310,000	US$27.6m	1.14%	22.9%
9.57%	Wubin Pan	6,026,813	US$12.5m	0%	no data
8.56%	Ikarian Capital, LLC	5,388,486	US$11.2m	12.5%	1.71%
8.43%	Suzhou Xiangtang Venture Investment Limited	5,306,149	US$11.0m	0%	no data
7.69%	Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	4,840,898	US$10.0m	0%	0.62%
7.56%	Advantech Capital Advisors II Limited	4,762,185	US$9.9m	0%	no data
6.16%	Zheng Wei	3,876,036	US$8.0m	-22.7%	no data
3.85%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	2,424,605	US$5.0m	0%	0.4%
1.96%	Boothbay Fund Management, LLC	1,234,582	US$2.6m	0%	0.05%
1.45%	LAV Investment Adviser Limited	912,302	US$1.9m	0%	100.0%
1.43%	683 Capital Management, LLC	900,000	US$1.9m	0%	0.15%
1.29%	BlackRock, Inc.	814,506	US$1.7m	0%	no data
1.26%	Perceptive Advisors LLC	792,696	US$1.6m	0%	0.03%
1.18%	ADAR1 Capital Management, LLC	742,400	US$1.5m	0%	0.08%
0.76%	Richmond Brothers, Inc.	476,584	US$986.5k	175%	0.58%
0.75%	Millennium Management LLC	474,601	US$982.4k	909%	no data
0.65%	BML Capital Management, LLC	408,887	US$846.4k	0%	0.45%
0.62%	Knott Partners Management, LLC	387,835	US$802.8k	93.9%	0.4%
0.49%	Stonepine Capital Management LLC	310,000	US$641.7k	0%	0.28%
0.44%	Susquehanna International Group, LLP	278,808	US$577.1k	290%	no data
0.36%	Barry Quart	224,034	US$463.7k	69.9%	no data
0.34%	David Szekeres	215,739	US$446.6k	34.1%	no data
0.32%	Diadema Partners LP	200,690	US$415.4k	0%	0.17%
0.25%	Propel Bio Management, LLC	159,118	US$329.4k	0%	0.27%
0.24%	Burkehill Global Management, LP	150,000	US$310.5k	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/05 02:27
End of Day Share Price	2026/08/05 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Connect Biopharma Holdings Limited is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Julian Harrison	BTIG
Edward Nash	Canaccord Genuity
Olivia Brayer	Cantor Fitzgerald & Co.